← All organizations
Highest phase reached
Phase 2
First clinical trial
Jan 1, 2014Last known activity
Feb 28, 2022
Timeline
2010s
- Jan 1, 2012
Iltoo Pharma— Founded
Drugs by trial phase (2 distinct, 9 trials)
Phase 2 (2 own, 0 via acquisition)
Indications
Studied for
- Abortion, Habitual
- Abortion, Spontaneous
- Acute Lung Injury
- Behcet Syndrome
- Bipolar Disorder
- Cholangitis
- Cholangitis, Sclerosing
- Crohn Disease
- Diabetes Mellitus
- Diabetes Mellitus, Type 1
- Granulomatosis with Polyangiitis
- Hepatitis, Autoimmune
- Hypersensitivity
- Lupus Erythematosus, Systemic
- Purpura
- Purpura, Thrombocytopenic
- Purpura, Thrombocytopenic, Idiopathic
- Respiratory Distress Syndrome
- Respiratory Distress Syndrome, Newborn
- Scleroderma, Systemic
- Spondylitis
- Spondylitis, Ankylosing
- Takayasu Arteritis
Recent trials (9)
- NCT05153070CollaboratorPhase 2Feb 28, 2022
- NCT04357444CollaboratorPhase 2Apr 30, 2020
- NCT04133233CollaboratorPhase 2Nov 30, 2019
- NCT03970954CollaboratorPhase 1/Phase 2Sep 30, 2019
- NCT03837093CollaboratorPhase 1May 1, 2019
- NCT03776643CollaboratorPhase 2Jan 23, 2019
- NCT02955615Lead sponsorPhase 2Nov 1, 2016
- NCT02411253CollaboratorPhase 2Jun 1, 2015
- NCT01988506CollaboratorPhase 2Jan 1, 2014
Details
- Founded
- Paris, FR Jan 1, 2012
- Last known activity
- Feb 28, 2022